The purpose of the study is to examine the efficacy and safety of adjunctive armodafinil for major depressive episodes associated with bipolar I disorder.

READ FULL ARTICLE Curated publisher From http://article.psychiatrist.com/dao_1-login.asp?ID=10008714&RSID=18168644551605